Compare HIND & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIND | GFAI |
|---|---|---|
| Founded | 2017 | 2018 |
| Country | United States | Singapore |
| Employees | 18 | 1657 |
| Industry | | Diversified Commercial Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8M | 15.9M |
| IPO Year | 2016 | N/A |
| Metric | HIND | GFAI |
|---|---|---|
| Price | $2.31 | $0.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $4.50 |
| AVG Volume (30 Days) | 23.2K | ★ 323.8K |
| Earning Date | 05-20-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.12 |
| Revenue Next Year | N/A | $10.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $0.38 |
| 52 Week High | $12.87 | $1.50 |
| Indicator | HIND | GFAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 47.15 |
| Support Level | $1.99 | $0.41 |
| Resistance Level | $2.36 | $0.60 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 77.88 | 57.84 |
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.